JPRN-UMIN000002419招募中1 期
Immunotherapy using WT1 peptide with surgical treatment, irradiation therapy, and Temozolomide administration against glioblastoma multiforme: A phase I/II study. - Immunotherapy using WT1 peptide with surgical treatment, irradiation therapy, and Temozolomide against glioblastoma multiforme
Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School0 个研究点目标入组 45 人开始时间: 2009年9月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients must be excluded: 1) Patients with uncontrollable infectious disease (including active Tuberculosis). 2) Patients with severe symptoms (malignant hypertension, severe congestive heart failure, severe colonary insufficiency, Myocardial Infarction within three months lately, terminal phase liver cirrhosis, uncontrollable Diabetes Mellitus, severe Pulmonary Fibrosis, active interstitial pneumonia, etc.). 3) Patients previously treated with Allogeneic bone marrow transplantation. 4) Patients who are pregnant and/or breast feeding, 5) Patients with severe psychiatric disease. 6) Patients who participate in any other clinical trial. 7) Patients who previously participated in this clinical trial. 8) Any patients disqualified by a study physician because of medical, psychological, or any other factors.
研究者
相似试验
招募中
1 期
W10TR-GBM2JPRN-jRCTs061180085eba Tetsuya90
已完成
1 期
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against malignant bone and soft tissue tumors: A phase I/II studyMalignant bone and soft tissue tumorsJPRN-UMIN000010257Department of Orthopaedic Surgery, Kochi Medical School20
已完成
不适用
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against Head and Neck Tumor: A phase I/II studyHead and Neck TumorJPRN-UMIN000001906Anti-tumor Immunotherapy Research Network, Department of Immunology, Kochi Medical School65
招募中
1 期
Immunotherapy using WT1 peptide and a pertussis whole cell vaccine against recurrent prostate cancer: A phase I/II studyProstate cancerJPRN-UMIN000001821Department of Immunology, Kochi University School of Medicine60
已完成
不适用
Immunotherapy using WT1 peptide against recurrent glioblastoma multiforme: A phase I/II study.glioblastoma multiformeJPRN-UMIN000002024Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School30